Abbott Says Recent Recall Of Some Bottles Of Infant Formula Will Not Hamper Supply - Abbott Laboratories (NYSE:ABT)

Abbott Laboratories ABT is voluntarily recalling some ready-to-feed baby formula liquid products, including Similac-branded items, due to inadequate sealing of some bottle caps.
The products included in the recall were manufactured at the Columbus, Ohio, manufacturing facility.
The recalled lots have bottle caps that may not have been sealed completely, resulting in spoilage.
If a spoiled product is consumed, gastrointestinal symptoms such as diarrhea and vomiting may occur.
In February, Abbott recalled dozens of Similac, Alimentum, and EleCare formulas, creating one of the most urgent food shortages in recent history for U.S. families.
This recall does not include other liquid or powder formula brands or nutrition products produced in the Columbus facility or elsewhere within our global nutrition manufacturing.
The recall, which equates to less than one day's worth of infant formula used in the United States, is not expected to impact the overall formula supply, Abbott said in a statement.
Abbott is continuing production of Similac Ready-to-Feed liquid formula products for hospitals and healthcare providers' offices on a different production line.
Last week, an FDA review concluded that numerous shortcomings hampered the agency's response to the U.S. infant formula supply problems this year.
Price Action: ABT shares closed at $100.97 on Friday.